Related Experiment Video
Updated: Jan 16, 2026

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
Published on: June 9, 2017
Membrane disruption attenuates agonist potency in prostanoid receptors
Uurtuya Hochban1, Imke Wallenstein1, Michaela Ulrich1
1Department of Pharmacy, Marburg University, Institute of Pharmacology and Clinical Pharmacy, Marburg, Germany.
Abstract:
G protein-coupled receptors (GPCRs) are key signal transducers and the target of about one-third of all FDA-approved drugs. Many structural and pharmacological studies rely on disrupted membrane conditions, such as purified receptors in artificial systems or radioligand binding assays using membrane fragments, even though it had not been systematically studied whether membrane integrity affects GPCR function. To address this, we developed Förster resonance energy transfer (FRET)-based GPCR conformation sensors to directly measure receptor activation in both intact and disrupted membranes. Our results show that while some GPCRs remain unaffected, prostanoid receptor conformation sensors exhibit a strong dependence on membrane integrity: their agonist and antagonist potencies decrease up to 30-fold upon membrane disruption, revealing a crucial role of the membrane integrity in ligand-receptor affinity. Validation with wildtype receptors in functional signaling assays confirmed that these effects reflect genuine receptor characteristics rather than unspecific signals from the sensor design. We ruled out several factors that could explain the loss of affinity but were unable to fully elucidate the mechanism behind this phenomenon. Nevertheless, this effect may introduce bias into structural and pharmacological studies. It is therefore essential to account for membrane integrity and to employ optimized experimental strategies to ensure robust and reliable data interpretation.
Related Concept Videos
GPCR Desensitization
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Opioid Receptors: Overview
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

